Post-dexamethasone cortisol correlates with severity of depression before and during carbamazepine treatment in women but not men

Acta Psychiatrica Scandinavica

Volumn 104, Issue 5, 2001, Pages 397-401

  Osuch, Elizabeth A ^a   Cora Locatelli, Gabriela ^b   Frye, Mark A ^c   Huggins, Teresa ^b   Kimbrell, Timothy A ^d   Ketter, Terence A ^e   Callahan, Ann M ^b   Post, Robert M ^b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carbamazepine; Cortisol; Depression; Dexamethasone; Gender; Menopause

Indexed keywords

CARBAMAZEPINE; DEXAMETHASONE; HYDROCORTISONE; PLACEBO;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEX DIFFERENCE;

ADULT; BIPOLAR DISORDER; CARBAMAZEPINE; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SEX FACTORS;

EID: 0035729997     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0447.2001.00395.x     Document Type: Article

References (39)

1. The effect of repeated human corticotropin-releasing hormone administration on dexamethasone-suppressed pituitary-adrenocortical activity in healthy subjects
2. CSF corticotropin-releasing hormone in depressed patients and normal control subjects
3. Adrenocorticotropic hormone, beta-endorphin and cortisol responses to oCRH in unipolar depressed patients pretreated with dexamethasone
4. Release of corticotropin after administration of corticotropin-releasing hormone in depressed patients in relation to the dexamethasone suppression test
5. Disrupted 24-hour patterns of cortisol secretion in psychotic depression
6. Cortisol secretion in endogenous depression. I. Basal plasma levels
7. Hypothalamic-pituitary-adrenal axis activity in depressive illness. Its relationship to classification
8. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility
9. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study
10. The multiple interactional biological processes that might lead to depression and gender differences in its appearance
11. Normalization of dexamethasone suppression test: A laboratory index of recovery from endogenous depression
12. Dexamethasone suppression test as indicator of safe withdrawal of antidepressant therapy
13. Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement
14. Correlation between the dexamethasone suppression test in depressed patients and clinical response
15. The dexamethasone suppression test during recurrent major depressive episodes
16. DST abnormality as a predictor of course in major depression
17. The DST as a predictor of outcome in depression: A meta-analysis
18. Prediction of outcome in depressed patients by weekly monitoring with the dexamethasone suppression test
19. Persistent neuroendocrine dysregulation in major depressive disorder: A marker for early relapse
20. Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects
21. The effect of anticonvulsants on the dexamethasone suppression test
22. Effect of carbamazepine on mean urinary free cortisol excretion in patients with major affective illness
23. Interference by carbamazepine with the dexamethasone suppression test
24. Effects of carbamazepine on pituitary-adrenal function in healthy volunteers
25. The influence of diphenylhydantoin and carbamazepine on the circadian rhythm of free urinary corticoids and on the suppressibility of the basal and the 'impulsive' activity by dexamethasone
26. Repeated dexamethasone suppression test in depressed patients
27. The dexamethasone suppression test, the Hamilton Depression rating scale and the DSM-III depression categories
28. The dexamethasone suppression test and sleep electroencephalogram in non-bipolar major depressed in-patients: A multivariate analysis
29. Sex-related differences in the relationships between self-rated depression and biological markers
30. Age-associated changes of pituitary-adrenocortical hormone regulation in humans: Importance of gender
31. Age and the dexamethasone suppression test: Results from a broad unselected patient population
32. Cortisol hypersecretion and cognitive impairment in depression
33. Age and gender effects on the diagnostic power of the DST
34. Antidepressant effects of carbamazepine
35. Methods for reliable longitudinal observation of behavior
36. Serum steroid hormones and pituitary function in female epileptic patients during carbamazepine therapy
37. Serum sex hormones are altered in patients with chronic temporal lobe epilepsy receiving anticonvulsant medication
38. The role of gonadal steroids in hypothalamic-pituitary-adrenal axis regulation
39. The epidemiology of affective disorders